RFC
CRDF icon

Russell Frank Company’s Cardiff Oncology CRDF Stock Holding History

Russell Frank Company’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,476
Closed -$1.08M – 3001
2015
Q2 		$1.08M Buy
+1,476
New +$1.05M ﹤0.01% 2271
2013
Q4 		– Sell
-796
Closed -$412K – 2850
2013
Q3 		$412K Buy
+796
New +$453K ﹤0.01% 2556

Other funds holding CRDF

BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $131M AUM 101.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Russell Frank Company's CRDF Position: Q3 2015 in Review

Russell Frank Company sold out of Cardiff Oncology (CRDF) in Q3 2015, closing a stake of 1,476 shares — an estimated $1.08M sold.

Russell Frank Company first reported a position in CRDF in Q3 2013 and held it in 2 quarters. The position peaked at $1.08M in Q2 2015. 60 funds tracked by Wall St. Rank hold CRDF as of Q3 2015.

  • Russell Frank Company reported no remaining Cardiff Oncology position as of Q3 2015 after selling out during the quarter.
  • Russell Frank Company sold 1,476 Cardiff Oncology shares in Q3 2015, an estimated $1.08M.
  • Russell Frank Company first reported a position in Cardiff Oncology in Q3 2013 and held it in 2 quarters.
  • Russell Frank Company's Cardiff Oncology position peaked at $1.08M in Q2 2015.
  • 60 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.